Shorter blood thinner use after GENOSS stent in heart disease
Part of Heart & circulation clinical trials.
This trial tests whether a shorter course of dual antiplatelet therapy (two blood thinners) is safe and effective for people who have received a GENOSS stent for coronary artery disease. It aims to reduce the risk of bleeding while still preventing heart attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have coronary artery disease and received a GENOSS drug-eluting stent (a type of small tube that opens blocked heart arteries and slowly releases medicine).
- You agree to follow the study plan and sign a consent form.
- You are not in cardiogenic shock (a condition where the heart suddenly can't pump enough blood).
- You are not pregnant or planning to become pregnant.
- Your life expectancy is at least 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking two blood thinners for one year after getting a special GENOSS stent is safe and works well for people with coronary artery disease, especially if the stent placement was complex. The goal is to prevent blood clots and keep your artery open.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new drug-coated stent (GENOSS® DES) for people with blockages in multiple heart arteries. It aims to see how safe and effective the stent is for these patients.
This trial tests if a shorter course of two blood thinners, guided by an ultrasound inside the arteries, is as safe and effective as the standard longer course in people who have had a stent placed for a heart attack or chest pain.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.